BRIC X-ray Systems Market Outlook to 2020

Researchmoz presents this most up-to-date research on"BRIC X-ray Systems Market Outlook to 2020". The report focuses primarily on quantitative market metrics in order to characterize the growth and evolution of the Remote Patient Monitoring Market.

Browse Full Report With TOC @ http://www.researchmoz.us/bric-x-ray-systems-market-outlook-to-2020-report.html

"BRIC X-ray Systems Market Outlook to 2020", provides key market data on the BRIC X-ray Systems market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories Analog X-ray Systems, Digital X-ray Systems (Computed Radiography (CR) Systems and Digital Radiography (DR) Systems) and Retrofit X-ray Systems.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the X-ray Systems market wherever available.

The data in the report is derived from dynamic market forecast models. Capital equipment based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

Browse Medical Imaging Related Research Reports @ http://www.researchmoz.us/medical-imaging-market-reports-59.html

Capital equipment based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

For Market Research Latest Reports Visit @ http://www.researchmoz.us/latest-report.html

Scope

Market size for X-ray Systems market categories Analog X-ray Systems, Digital X-ray Systems (Computed Radiography (CR) Systems and Digital Radiography (DR) Systems) and Retrofit X-ray Systems.
Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020.
2012 company shares and distribution shares data for the market category.
Global corporate-level profiles of key companies operating within the BRIC X-ray Systems market.
Key players covered include GE Healthcare, Philips Healthcare, Siemens Healthcare, Carestream Health, Inc., Shimadzu Corporation, Toshiba Medical Systems Corporation and General Medical Merate S.p.A.

Browse All Category Wise Research Reports @ http://www.researchmoz.us/category.html

Reasons to buy

Develop business strategies by identifying the key market segments poised for strong growth in the future.
Develop market-entry and market expansion strategies.
Design competition strategies by identifying who-stands-where in the market.
Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
What are the key distribution channels and whats the most preferred mode of product distribution Identify, understand and capitalize. 

For More Information Kindly Contact:
Email: sales@researchmoz.us
WebSite: http://www.researchmoz.us/
Blog: http://globalandchinamarket.blogspot.com

BRIC MRI Systems Market Outlook to 2020

Researchmoz presents this most up-to-date research on"BRIC MRI Systems Market Outlook to 2020". The report focuses primarily on quantitative market metrics in order to characterize the growth and evolution of the Remote Patient Monitoring Market.

"BRIC MRI Systems Market Outlook to 2020", provides key market data on the BRIC MRI Systems market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories High Field MRI Systems, Low Field MRI Systems and Mid Field MRI Systems.

Get Full Report With TOC @ http://www.researchmoz.us/bric-mri-systems-market-outlook-to-2020-report.html

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the MRI Systems market wherever available.
 

Capital equipment based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Get Medical Imaging Related Research Reports @ http://www.researchmoz.us/medical-imaging-market-reports-59.html

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope
Market size for MRI Systems market categories High Field MRI Systems, Low Field MRI Systems and Mid Field MRI Systems.
Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020.
2012 company shares and distribution shares data for each of the market categories.
Global corporate-level profiles of key companies operating within the BRIC MRI Systems market.
Key players covered include GE Healthcare, Hitachi Medical Corporation, Philips Healthcare, Siemens Healthcare and Toshiba Medical Systems Corporation

For All Category Wise Research Reports Visit @ http://www.researchmoz.us/category.html

Reasons to buy
Develop business strategies by identifying the key market segments poised for strong growth in the future.
Develop market-entry and market expansion strategies.
Design competition strategies by identifying who-stands-where in the market.
Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
What are the key distribution channels and whats the most preferred mode of product distribution Identify, understand and capitalize.

For More Information Kindly Contact:
Email: sales@researchmoz.us
WebSite: http://www.researchmoz.us/
Blog: http://medicaldevicesmarket.blogspot.com

BRIC Ultrasound Systems Market Outlook to 2020

Researchmoz presents this most up-to-date research on"BRIC Ultrasound Systems Market Outlook to 2020". The report focuses primarily on quantitative market metrics in order to characterize the growth and evolution of the Remote Patient Monitoring Market.

"BRIC Ultrasound Systems Market Outlook to 2020", provides key market data on the BRIC Ultrasound Systems market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories B/W Ultrasound Systems (Portable Systems (B/W) and Stand Alone Systems (B/W)) and Color Ultrasound Systems (Portable Systems and Stand Alone Systems).

Browse Full Report With TOC @ http://www.researchmoz.us/bric-ultrasound-systems-market-outlook-to-2020-report.html

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Ultrasound Systems market wherever available.The data in the report is derived from dynamic market forecast models. GlobalData uses capital equipmentbased models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

Capital equipment based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Market Research Medical Imaging Related Reports :

X-Ray Equipment Markets in the World to 2018 - Market Size, Trends, and Forecasts http://www.researchmoz.us/x-ray-equipment-markets-in-the-world-to-2018-market-size-trends-and-forecasts-report.html

The reports include historic market data from 2007 to 2013 and forecasts until 2018 which makes the reports an invaluable resource for industry executives, marketing, sales and product managers, analysts, and other people looking for key industry data in readily accessible and clearly presented tables and graphs.The expansion of the global X-ray equipment industry is forecast to reach 5.7% p.a. in the coming years. Between 2007 and 2013 the market increased with an average annual growth of 5.4%. Currently, medical X-ray equipment account for 52.6% of the global demand while the remaining market share is divided between non-medical X-ray equipment (22.4%), X-ray tubes (17.8%), and dental X-ray equipment (7.2%).China, Germany, Italy, Japan, and the United States represent the largest X-ray equipment markets while the strongest annual growth is forecast to occur in Iran (15.1%), Moldova (13.4%), Lithuania (13.2%), Latvia (13.2%), and Sri Lanka (13.1%). This industry report package offers the most up-to-date market data on the actual market situation, trends, and future outlook for X-ray equipment in the world.

China MRI Systems Market Outlook to 2020 http://www.researchmoz.us/china-mri-systems-market-outlook-to-2020-report.html

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the MRI Systems market wherever available.The data in the report is derived from dynamic market forecast models. GlobalData uses capital equipmentbased models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.Capital equipmentbased forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

For More Related Research Reports Visit @ http://www.researchmoz.us/medical-imaging-market-reports-59.html

Scope
Market size for Ultrasound Systems market categories B/W Ultrasound Systems (Portable Systems (B/W) and Stand Alone Systems (B/W)) and Color Ultrasound Systems (Portable Systems and Stand Alone Systems).
Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020.
2012 company shares and distribution shares data for the market category.
Global corporate-level profiles of key companies operating within the BRIC Ultrasound Systems market.
Key players covered include Fujifilm Holdings Corporation, GE Healthcare, Hitachi Medical Corporation, Mindray Medical International Limited, Philips Healthcare, Siemens Healthcare and Toshiba Medical Systems Corporation.

Browse Latest Research Reports @ http://www.researchmoz.us/latest-report.html

For More Information Kindly Contact:
Email: sales@researchmoz.us
WebSite: http://www.researchmoz.us/
Blog: http://medicaldevicesmarket.blogspot.com

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2022

Researchmoz presents this most up-to-date research on"PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2022". The report focuses primarily on quantitative market metrics in order to characterize the growth and evolution of the Remote Patient Monitoring Market.

During the forecast period from 20122022, the growth of the UC market will be driven largely by the entry of Johnson & Johnsons (J&Js) Simponi and Takedas Entyvio, which will lead to an increase in the overall number of patients being treated with biologics in the US, 5EU, Japan, and Canada.

Get Full Report With TOC @ http://www.researchmoz.us/pharmapoint-ulcerative-colitis-global-drug-forecast-and-market-analysis-to-2022-report.html

Another key event affecting the UC market is the anticipated launch of biosimilars, given that the patent expiry of the UC blockbusters, Remicade and Humira are set to expire in the US in 2018 and 2016, respectively.

• Overall, major barriers to the growth of the UC market include  
• Remicade and Humira losing patent protection in the midforecast
• Austerity measures favoring generic prescribing
• Biosimilars are predicted to face low uptake due to the lack of regulatory guidelines in some markets, such as the US

In 2012, estimates that the global UC market reached $4.2 billion across the 10 healthcare markets covered in our forecast: the US, France, Germany, Italy, Spain, the UK, Japan, Canada, China, and India. By the end of the forecast period, in 2022, sales across these markets will grow steadily to reach $6.6 billion, representing a Compound Annual Growth Rate (CAGR) of 4.8% over the 10year timeframe.

Browse Healthcare Related Research Reports @ http://www.researchmoz.us/healthcare-market-reports-56.html

Highlights

Key Questions Answered

• How will the UC market (sales and patient numbers) evolve over the 10year forecast period from 2012 to 2022?
• Which brands and specific drug classes did physicians select for their UC patients in 2012 and how do they foresee their prescribing behavior evolving over the next five years?
• How will the launch of latestage pipeline therapies such as Entyvio and Kappaproct shape the future treatment landscape?
• What are the remaining unmet needs and opportunities for drug developers within the UC market?

Key Findings

• The UC market has predominantly been driven by two TNF blockers, namely J&Js Remicade and AbbVies Humira. Although these TNF blockers have monopolized the UC market for almost a decade, the balance is about to be tipped, with Takedas Entyvio imminently entering the market in 2014 and J&Js Simponi launching in 2014 as well, stealing market share from Humira and Remicade.
• Remicade and Humira will also be hit by their respective loss of patent protection in 2018 (US), 2015 (EU) and 2016 (US), 2018 (EU). Europe has already approved a biosimilar to Remicade, Celltrions Remsima, which will be marketed by Hospira under the brand name Inflectra in the EU.

For All Category Wise Research Reports Visit @ http://www.researchmoz.us/category.html

Scope

• Overview of UC, including epidemiology, etiology, pathophysiology, symptoms, diagnosis, and current treatment options. 
• Annualized UC therapeutics market revenue, annual cost of therapy and treatment usage pattern data from 2012 to 2022.
• Key topics covered include strategic competitor assessment, market characterization, unmet needs, and implications for the UC therapeutics markets.
• Pipeline analysis: comprehensive data split across different phases, emerging novel trends under development, and detailed analysis of late stage pipeline drugs.
• Analysis of the current and future market competition in the global UC therapeutics markets. Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

For More Information Kindly Contact:
Email: sales@researchmoz.us
Web Site: http://www.researchmoz.us/
Blog: http://globalandchinamarket.blogspot.com

PharmaPoint: Migraine US and 5EU Drug Forecast and Market Analysis to 2023

ResearchMoz.us include new market research report"PharmaPoint: Migraine US and 5EU Drug Forecast and Market Analysis to 2023"to its huge collection of research reports.

PharmaPoint: Migraine - US Drug Forecast and Market Analysis to 2023 http://www.researchmoz.us/pharmapoint-migraine-us-drug-forecast-and-market-analysis-to-2023-report.html

The migraine market is saturated with generic drugs, and the remaining branded products already on the market are expected to lose exclusivity during the next few years, with the exception of Botox for chronic migraine, which is expected to maintain its leading position in terms of sales. However, reformulations of mature products as well as new classes of therapies are anticipated to launch during the forecast period and these will contribute to the market growth. By 2023, the migraine market will grow to $3.7 billion at a compound annual growth rate (CAGR) of 3.6%, with the US continuing to dominate the market as a result of higher drug prices and a large migraine population. Some of the new treatments are expected to target the key unmet needs but opportunities will remain for further treatment choices especially drugs that will offer an improved safety and side-effects profile.

The US migraine market is the largest given its population size and high drug prices. The main growth driver during this period will be Allergans Botox, in addition to the launch of new combinations of drug and device and new classes of acute therapy. Historically the triptans have dominated the acute migraine segment and although the gold standard, GSKs Imitrex, expired in 2008, it has remained as one of the most popular triptans among physicians. A recent trend in this segment is the development of devices that can deliver drugs in a more effective way, such as Sumavel DosePro, a needle-free injection of sumatriptan.

Browse Healthcare Related Research Reports @ http://www.researchmoz.us/healthcare-market-reports-56.html

Scope
Overview of Migraine including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
Detailed information on the key drugs in the US including product description, safety and efficacy profiles as well as a SWOT analysis.
Sales forecast for the top drugs in the US from 2012-2023.
Analysis of the impact of key events as well the drivers and restraints affecting the US Migraine market.

PharmaPoint: Migraine - 5EU Drug Forecast and Market Analysis to 2023 http://www.researchmoz.us/pharmapoint-migraine-5eu-drug-forecast-and-market-analysis-to-2023-report.html

By 2023, the migraine market will grow to $3.7 billion at a compound annual growth rate (CAGR) of 3.6%, with the US continuing to dominate the market as a result of higher drug prices and a large migraine population. Some of the new treatments are expected to target the key unmet needs but opportunities will remain for further treatment choices especially drugs that will offer an improved safety and side-effects profile.

Each of the countries included in this report provide guidelines for the treatment of migraine. According to high-prescriber survey, the US, UK and Japan strongly adhere to their own national guidelines; however, the majority of the physicians from other EU countries (France, Germany, Italy and Spain) follow European guidelines such as the European Headache Federation (EHF) and European Federation of Neurological Societies (EFNS) guidelines.

Scope
Overview of Migraine including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
Detailed information on the key drugs in 5EU including product description, safety and efficacy profiles as well as a SWOT analysis.
Sales forecast for the top drugs in 5EU (the UK, France, Italy, Spain, Germany) from 2012-2023.
Analysis of the impact of key events as well the drivers and restraints affecting the US Migraine market.

For More Information Kindly Contact:
Email: sales@researchmoz.us
Web Site: http://www.researchmoz.us/
Blog: http://globalandchinamarket.blogspot.com
word press : http://marketresearchtopix.wordpress.com

Research Report on Medical Industry in China 2014 - 2018

Researchmoz presents this most up-to-date research on"Research Report on Medical Industry in China 2014 - 2018". The report focuses primarily on quantitative market metrics in order to characterize the growth and evolution of the Remote Patient Monitoring Market.

In China, medical institutions refer to licensed (the Practice License of Medical Institutions) hospitals, health centers, clinics and first-aid stations that diagnose and treat diseases.

Get Full Report With TOC @ http://www.researchmoz.us/research-report-on-medical-industry-in-china-2014-2018-report.html

As a public service provider, medical institutions are regulated by National Health and Family Planning Commission of China and other related government departments. Uneven regional distribution of medical resources exhibits the uneven economic development in aspects of medical institution classification, assets scale, revenue and expenditure, and distribution of private and foreign-funded medical institutions for profits. Developed regions like Shanghai, Beijing, Guangdong and Zhejiang have more advanced medical technology.

According to the Chinese government, the total medical expense was approximately CNY 2,891.44 billion (about USD 466 billion) in 2012, up by 18.8% compared with that in 2011. The medical expense per capita was CNY 2,135.8 (approximately USD 344) at a growth rate of 18.2%. The total medical expense and expense per capita are increasing rapidly due to economic growth and population aging. In 2012, the total medical expense accounted for 5.57% of GDP, 0.42% higher than that in 2011. However, the percentage was much lower than that in developed countries. 

The number of medical institutions was 0.962 million by the end of November 2013, including 24,000 hospitals, 0.923 million primary medical institutions, 12,000 public medical institutions and 2,000 other institutions. The number of hospitals and public medical institutions increased by 1,564 and 247 respectively while that of primary medical institutions decreased by 1,606 compared with those in November 2012. 

Browse Healthcare Related Research Reports @ http://www.researchmoz.us/healthcare-market-reports-56.html

The number of visits in medical institutions reached 6.41 billion in January to November 2013, up by 8.2% YOY, including 2.41 billion in hospitals (up by 9.5% YOY), 3.79 billion in primary medical institutions (up by 7.3% YOY) and 0.21 billion in other institutions. The number of visits in public hospitals was 2.17 billion (up by 8.9% YOY) while that in private hospitals was 0.24 billion, up by 15.6% YOY, which exhibits rapid development of private hospitals in China. 

The new government attempts to reform the medical system which exhibits great market potential. According to CRI, new entrants such as private and foreign-funded enterprises are bullish about the prospect of the medical industry due to the reform measures. New medical institutions need at least 3-5 years to make profits while M&A institutions need much shorter period of time by taking advantage of the existing employees, equipment and patients of the purchased medical institutions. 

Browse Market Research Latest Reports @ http://www.researchmoz.us/latest-report.html

Through this report, the readers can acquire the following information:

• Development Environment of Medical Industry in China
• Supply and Demand Status of Medical Industry in China
• Segmented Markets in China Medical Industry
• Market Competition of Medical Industry in China
• Investment Opportunities in China Medical Industry
• Development Trend of Medical Industry in China

For More Information Kindly Contact:
Email: sales@researchmoz.us
Web Site: http://www.researchmoz.us/
Blog: http://deepmarketresearchreports.blogspot.com/
word press : http://marketresearchtopix.wordpress.com

In-Vitro Diagnostics Industry Analysis till 2018 - Accreditation and Automation to Drive Future Growth

Researchmoz presents this most up-to-date research on"India In-Vitro Diagnostics Industry Analysis till 2018 - Accreditation and Automation to Drive Future Growth". The report focuses primarily on quantitative market metrics in order to characterize the growth and evolution of the Remote Patient Monitoring Market.

Browse Full Report With TOC @ http://www.researchmoz.us/india-in-vitro-diagnostics-industry-analysis-till-2018-accreditation-and-automation-to-drive-future-growth-report.html

The report titled India In-Vitro Diagnostics Industry Analysis till 2018 Accreditation and Automation to Drive Future Growth provides a comprehensive analysis of the various aspects such as market size of the India in-vitro diagnostics market, India immunochemistry market, India biochemistry market, India hematology market, India microbiology market, India blood gas and electrolyte market, India molecular diagnostics market, India urinalysis market and India coagulation market. The report also covers the market shares of major players in the immunochemistry, biochemistry and microbiology space as well as the overall in-vitro diagnostics market in India.

In-vitro diagnostics market in India, which has hugely been driven by the increasing number of lifestyle diseases, inclining preventive healthcare practices, mounting disposable incomes, governments initiatives and improving healthcare infrastructure, registered revenues of USD ~ million in FY2013. With the advent of new varieties of diagnostic tests incorporating latest technology, the revenues increased by 25.8% compared to FY2012, where the total revenues were USD ~ million.

Browse Market Research Healthcare Related Reports @ http://www.researchmoz.us/healthcare-market-reports-56.html

The in-vitro diagnostics market in India is comprised of various manufacturers that specialize in the development and production of diagnostic products in different segments. Along with the presence of leading diagnostic companies in the organized sector, market in India is also driven by the revenues of a huge number of manufacturers in the unorganized segment. Roche was the market leader in the overall IVD market India, while also dominating the immunochemistry and biochemistry segments in fiscal year 2013. In addition to the prevalence of several players in the organized segment, the market is also driven by the imports of numerous diagnostic products from China and other countries

The market for in-vitro diagnostics in India is changing at a brisk rate. Technological advancements, demand of diagnostic tests from an ever growing base of disease-ridden population, and people suffering from lifestyle diseases, as well as the transition of diagnostic product manufacturers from the unorganized to the organized segment have been significantly changing the market. Revenues from the in-vitro diagnostics market in India are expected to expand to USD ~ million in FY2018, growing with a CAGR of ~% from FY2013 to FY2018.

For All Category Wise Research Reports Visit @ http://www.researchmoz.us/category.html

KEY TOPICS COVERED IN THE REPORT

• The market size of the India in-vitro diagnostics market.
• The market size of the India immunochemistry market.
• The market size of the India immunochemistry reagents and instruments.
• The market size of the India biochemistry market.
• The market size of the India hematology market.
• The market size of the India microbiology market.
• Market segmentation of the India in-vitro diagnostics market on the basis of type of tests, contribution from reagents and instruments, and contribution from urban and rural areas.

For More Information Kindly Contact:
Email: sales@researchmoz.us
Web Site: http://www.researchmoz.us/
Blog: http://globalandchinamarket.blogspot.com
word press : http://marketresearchtopix.wordpress.com